The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSophos Group Regulatory News (SOPH)

  • There is currently no data for SOPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme of arrangement

8 Nov 2019 12:23

RNS Number : 8358S
Sophos Group Plc
08 November 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

8 November 2019

RECOMMENDED CASH ACQUISITION

of

SOPHOS GROUP plc

by

SURF BUYER Limited

(a newly formed company owned by funds managed and/or advised by Thoma Bravo, LLC)to be effected by means of a Scheme of Arrangement underPart 26 of the Companies Act 2006

 

PUBLICATION OF THE SCHEME DOCUMENT

On 14 October 2019, the board of directors of Sophos Group plc ("Sophos") and the board of directors of Surf Buyer Limited ("Bidco") announced that they had agreed the terms of a recommended cash offer pursuant to which Bidco will acquire the entire issued and to be issued share capital of Sophos, to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act (the "Scheme").

Publication of the Scheme Document

Sophos is pleased to announce that a circular in relation to the Scheme (the "Scheme Document") setting out, among other things, a letter from the Chairman of Sophos, the full terms and conditions of the Scheme, a statutory explanatory statement, an expected timetable of principal events, notices of the Court Meeting and General Meeting and details of the actions to be taken by Sophos Shareholders has been published today on Sophos' website at https://investors.sophos.com.

Hard copies of the Scheme Document (or, depending on the Sophos Shareholders' communication preferences, a letter or email giving details of the website where the Scheme Document may be accessed), the Forms of Proxy for the Court Meeting and the General Meeting and the Form of Election are being sent to Sophos Shareholders. Sophos Shareholders may request hard copies of the Scheme Document, the Forms of Proxy for the Court Meeting and the General Meeting and the Form of Election by calling Link Asset Services on +44 (0)371 664 0321 or by writing to Link Asset Services at Link Asset Services, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU stating the name and address to which the hard copy should be sent.

Capitalised terms in this announcement, unless otherwise defined, have the same meanings as set out in the Scheme Document. All references to times in this announcement are to London times unless otherwise stated.

Action required

As further detailed in the Scheme Document, in order to become effective, the Scheme will require, among other things, that the requisite majority of Sophos Shareholders vote in favour of the Scheme at the Court Meeting and the Special Resolution at the General Meeting. The Scheme is also subject to the satisfaction or waiver of the Conditions and further terms that are set out in the Scheme Document.

Notices convening the Court Meeting and the General Meeting at 11:00 am (London time) on 3 December 2019 and 11:15 am (London time) (or immediately after the conclusion or adjournment of the Court Meeting) on 3 December 2019, respectively, to be held at The Pentagon, Abingdon Science Park, Abingdon, United Kingdom, OX14 3YP are set out in the Scheme Document. 

The Sophos Directors, who have been so advised by J.P. Morgan Cazenove, Lazard and UBS as to the financial terms of the Acquisition, consider the terms of the Acquisition to be fair and reasonable. In providing their financial advice to the Sophos Directors, J.P. Morgan Cazenove, Lazard and UBS have taken into account the commercial assessments of the Sophos Directors. Lazard is providing independent financial advice to the Sophos Directors for the purposes of Rule 3 of the Code.

The Sophos Directors consider the terms of the Acquisition to be in the best interests of Sophos and its shareholders taken as a whole. Accordingly, the Sophos Directors unanimously recommend that Sophos Shareholders vote in favour of the Scheme at the Court Meeting and the Special Resolution relating to the Acquisition to be proposed at the General Meeting, as the Sophos Directors who hold Sophos Shares in their own name or through a nominee have irrevocably undertaken to do in respect of their own beneficial holdings of Sophos Shares (or those Sophos Shares over which they have control).

It is important that, for the Court Meeting in particular, as many votes as possible are cast so that the Court may be satisfied that there is a fair and reasonable representation of opinion of the Scheme Shareholders. Scheme Shareholders are therefore strongly advised to complete, sign and return their blue Form of Proxy or appoint a proxy electronically, for the Court Meeting as soon as possible.

Sophos Shareholders should carefully read the Scheme Document in its entirety before making a decision with respect to the Scheme.

Timetable

The Scheme Document contains an expected timetable of principal events relating to the Scheme, which is also set out in the Appendix to this announcement. The Scheme remains conditional on the approval of Scheme Shareholders at the Court Meeting and Sophos Shareholders at the General Meeting and to the satisfaction or waiver of the other Conditions set out in the Scheme Document, including the approval of the Court. The Scheme is expected to become effective in the first quarter of 2020 and an update to the expected timetable will be announced following receipt of relevant antitrust and regulatory clearances.

Information for Sophos Shareholders

Copies of this announcement and the Scheme Document will be available (subject to certain restrictions relating to persons in certain overseas jurisdictions) on Sophos' website at https://investors.sophos.com by no later than 12:00 p.m. (London time) on the Business Day following this announcement, up to and including the Effective Date.

A copy of the Scheme Document will shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

If you have any questions about this announcement, the Scheme Document, the Court Meeting or the General Meeting, or are in any doubt as to how to appoint a proxy or make use of the Currency Election, please call Link Asset Services between 8:30 a.m. and 5:30 p.m. Monday to Friday (except UK public holidays) on +44 (0)371 664 0321. Calls will be charged at national or international rates as the case may be. Different charges may apply to calls from mobile telephones. Please note that calls may be monitored or recorded and Link Asset Services cannot provide legal, tax or financial advice or advice on the merits of the Scheme

Enquiries:

Sophos Group plc

Kris Hagerman, Chief Executive OfficerDerek Brown, Vice President Investor Relations

 

 

Tel: +44 (0) 12 3555 9933

 

Tulchan Communications (financial PR adviser to Sophos)

James Macey White

 

Sunni Chauhan

 

Harry Cameron

 

Matt Low

 

Tel: +44 (0)20 7353 4200

 

J.P. Morgan Cazenove (lead financial adviser and corporate broker to Sophos)

Gary Weiss

 

Bill Hutchings

 

James Robinson

 

Chris Wood

 

Tel: +44 (0) 20 7742 4000

Lazard (financial adviser and Rule 3 adviser to Sophos)

 

Cyrus Kapadia

 

Philippe Noël

 

Tel: +44 (0)20 7187 2000

UBS AG London Branch (corporate broker and financial adviser to Sophos)

Jonathan Rowley

 

David Roberts

 

Tel: +44 (0)20 7567 8000

 

Finsbury (PR adviser to Bidco and Thoma Bravo)

Faeth Birch

 

Edward Simpkins

Tel: +44 (0) 20 7251 3801

 

Goldman Sachs (financial adviser to Bidco and Thoma Bravo)

Ward Waltemath

Mark Sorrell

Chris Emmerson

Jimmy Bastock (Corporate Broking)

 

 

Tel: +1 212 902 1000

Tel: +44 (0) 20 7774 1000

Tel: +44 (0) 20 7774 1000

Tel: +44 (0) 20 7774 1000

 

 

Kirkland & Ellis International LLP is acting as legal adviser to Thoma Bravo and Bidco.

Slaughter and May is acting as legal adviser to Sophos. 

 

APPENDIXEXPECTED TIMETABLE OF PRINCIPAL EVENTS

The following indicative timetable is based on Sophos' and Bidco's current expected dates for the implementation of the Scheme and is subject to change. If any of the dates and/or times in this expected timetable change, the revised dates and/or times will be notified to Sophos Shareholders by announcement through the Regulatory Information Service of the London Stock Exchange.

 

Event

Time and/or date(1)

Publication of the Scheme Document

 8 November 2019

Latest time for lodging Forms of Proxy for the:

 

Court Meeting (blue form)

11:00 a.m. on 29 November 2019(2)

General Meeting (yellow form)

11:15 a.m. on 29 November 2019(3)

Voting Record Time

8:00 p.m. on 29 November 2019(4)

Court Meeting

11:00 a.m. on 3 December 2019

General Meeting

11:15 a.m. on 3 December 2019(5)

The following dates and times associated with the Scheme are subject to change and will depend on, among other things, the date on which the Conditions to the Scheme are satisfied or, if capable of waiver, waived, and the date on which the Court sanctions the Scheme. Sophos will give adequate notice of all of these dates and times, when known, by issuing an announcement through a Regulatory Information Service, with such announcement being made available on Sophos' website at https://investors.sophos.com. Further updates and changes to these times will be notified in the same way. See also note (1).

Scheme Court Hearing

a date expected to be in the first quarter of 2020 and, in any event, prior to the Long Stop Date, subject to the satisfaction (or, if applicable, waiver) of Conditions 3(A) to (D) (inclusive) ("D")

Last time for receipt of red Form of Election or TTE Instructions relating to Currency Election

1:00 p.m. on D

Last day for dealings in, and for the registration of transfer of, Sophos Shares

D+1 Business Day

Scheme Record Time

8:00 p.m. on D+1 Business Day

Disablement of CREST in respect of Sophos Shares

8:00 p.m. on D+1 Business Day

Suspension of dealings in Sophos Shares

by 7:30 a.m. on D+2 Business Day

Effective Date of the Scheme

D+2 Business Days

Cancellation of listing of Sophos Shares

by 7:30 a.m. on D+3 Business Days

Latest date for despatch of cheques and crediting of CREST accounts for cash consideration due under the Scheme

within 14 days of the Effective Date

Long Stop Date(6)

26 June 2020

 

(1) The dates and times given are indicative only and are based on current expectations and are subject to change (including as a result of changes to the regulatory timetable).

References to times are to London, United Kingdom time unless otherwise stated. If any of the times and/or dates above change, the revised times and/or dates will be notified to Sophos Shareholders by announcement through a Regulatory Information Service.

Participants in the Sophos Share Plans will be written to separately to inform them of the effect of the Scheme on their rights under the Sophos Share Plans, including details of any appropriate proposals being made and dates and times relevant to them.

(2) It is requested that blue Forms of Proxy for the Court Meeting be lodged not later than 48 hours prior to the time appointed for the Court Meeting or, if the Court Meeting is adjourned, the time fixed for any adjourned Court Meeting (excluding any part of such 48 hour period falling on a non-working day). If the blue Form of Proxy for the Court Meeting is not returned by the above time, it may be handed to a representative of Link Asset Services or to the Chairman of the Court Meeting before the start of that Meeting.

(3) In order to be valid, the yellow Forms of Proxy for the General Meeting must be received by 11:15 a.m. on 29 November 2019 or, if the General Meeting is adjourned, 48 hours prior to the time fixed for the adjourned General Meeting (excluding any part of such 48 hour period falling on a non-working day).

(4) If either the Court Meeting or the General Meeting is adjourned, the Voting Record Time for the relevant adjourned meeting will be 8:00 p.m. on the day which is two days (excluding non-working days) prior to the date of the adjourned meeting.

(5) To commence at 11:15 a.m. or as soon thereafter as the Court Meeting shall have concluded or been adjourned.

(6) This is the latest date by which the Scheme may become effective. However, the Long Stop Date may be extended to such later date as Sophos and Bidco may agree in writing (with the Panel's consent and as the Court may approve (if such consent and/or approval is/are required)).

 

Important notices

Goldman Sachs International, which is authorised by the PRA and regulated by the FCA and the PRA in the United Kingdom, and Goldman Sachs & Co. LLC (together "Goldman Sachs") are acting exclusively for Bidco and Thoma Bravo as financial advisers and no one else in connection with the Acquisition, this announcement or any matter referred to herein and will not be responsible to anyone other than Bidco and Thoma Bravo for providing the protections afforded to clients of Goldman Sachs, nor for providing advice in connection with the Acquisition, this announcement or any matter referred to herein. Neither Goldman Sachs nor any of Goldman Sachs' subsidiaries, affiliates or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs in connection with the Acquisition, this announcement, any matter referred to herein or otherwise.

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the PRA and regulated by the PRA and the FCA. J.P. Morgan Cazenove is acting as financial adviser exclusively for Sophos and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Sophos for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, or for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

Lazard & Co., Limited ("Lazard"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser to Sophos and no one else in connection with the Acquisition and will not be responsible to anyone other than Sophos for providing the protections afforded to clients of Lazard nor for providing advice in connection with the Acquisition or any other matter referred to herein. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with the Acquisition, any statement contained herein or otherwise.

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting exclusively as financial adviser to Sophos and no one else for the purpose of the Acquisition and will not be responsible to anyone other than Sophos for providing the protections offered to clients of UBS nor for providing advice in relation to the Acquisition or any transaction, arrangement or other matter referred to herein.

In accordance with the Code, Goldman Sachs International, J.P. Morgan Cazenove and UBS and their respective affiliates will continue to act as exempt principal trader in Sophos securities on the London Stock Exchange. These purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the United States to the extent that such information is made public in the United Kingdom.

Further information

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise. The Acquisition will be made solely pursuant to the terms of the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the Offer Document), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any decision in respect of, or other response to, the Acquisition should be made only on the basis of the information in the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the Offer Document).

This announcement does not constitute a prospectus or prospectus equivalent document.

Overseas Shareholders

This announcement has been prepared in accordance with English law, the Code, the Market Abuse Regulation and the Disclosure Guidance and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

The availability of the Acquisition to Sophos Shareholders who are not resident in and citizens of the UK may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Persons who are not resident in the UK should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. In particular, the ability of persons who are not resident in the United Kingdom to vote their Sophos Shares with respect to the Scheme at the Court Meeting, or to appoint another person as proxy to vote at the Court Meeting on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. Further details in relation to Overseas Shareholders will be contained in the Scheme Document.

Unless otherwise determined by Bidco or required by the Code, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Scheme by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of an Offer (unless otherwise permitted by applicable law and regulation), the Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.

Notice to US investors in Sophos

The Acquisition relates to the shares of an English company and is being made by means of a scheme of arrangement provided for under English company law. A transaction effected by means of a scheme of arrangement is not subject to the tender offer or proxy solicitation rules under the US Exchange Act of 1934. Accordingly, the Acquisition is subject to the disclosure requirements and practices applicable in the UK to schemes of arrangement which differ from the disclosure requirements of the US tender offer and proxy solicitation rules. The financial information included in this announcement has been prepared in accordance with generally accepted accounting principles of the United Kingdom and thus may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States.

If, in the future, Bidco exercises its right to implement the Acquisition by way of an Offer, which is to be made into the United States, such Offer will be made in compliance with the applicable US laws and regulations.

It may be difficult for US holders of Sophos Shares to enforce their rights and any claim arising out of the US federal laws, since Bidco and Sophos are located in a non-US jurisdiction, and some or all of their officers and directors may be residents of a non-US jurisdiction. US holders of Sophos Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement.

Forward looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Acquisition, and other information published by Bidco and Sophos contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Bidco and Sophos about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

The forward-looking statements contained in this announcement include statements relating to the expected effects of the Acquisition on Bidco and Sophos (including their future prospects, developments and strategies), the expected timing and scope of the Acquisition and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "projects", "strategy", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved (or, in each case, their negative or other variations). Although Bidco and Sophos believe that the expectations reflected in such forward-looking statements are reasonable, Bidco and Sophos can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements.

These factors include, but are not limited to: the ability to complete the Acquisition; the ability to obtain requisite regulatory and shareholder approvals and the satisfaction of other Conditions on the proposed terms and schedule; as future market conditions, changes in general economic and business conditions, the behaviour of other market participants, the anticipated benefits from the proposed transaction not being realised as a result of changes in general economic and market conditions in the countries in which Bidco and Sophos operate, weak, volatile or illiquid capital and/or credit markets, changes in tax rates, interest rate and currency value fluctuations, the degree of competition in the geographic and business areas in which Bidco and Sophos operate, the consequences in the UK and globally from the withdrawal of the UK from the European Union, and changes in laws or in supervisory expectations or requirements. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors. Neither Bidco nor Sophos, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place any reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, neither Bidco nor Sophos is under any obligation, and Bidco and Sophos expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Dealing and Opening Position Disclosure Requirements of the City Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an Offeree company or of any securities exchange Offeror (being any Offeror other than an Offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange Offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the Offeree company and (ii) any securities exchange Offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm on the 10th business day following the announcement in which any securities exchange Offeror is first identified. Relevant persons who deal in the relevant securities of the Offeree company or of a securities exchange Offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the Offeree company or of any securities exchange Offeror must make a Dealing Disclosure if the person deals in any relevant securities of the Offeree company or of any securities exchange Offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the Offeree company and (ii) any securities exchange Offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an Offeree company or a securities exchange Offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the Offeree company and by any Offeror and Dealing Disclosures must also be made by the Offeree company, by any Offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the Offeree and Offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any Offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on website

 

This announcement and the documents required to be published pursuant to Rule 26 of the Code will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Sophos' website at https://investors.sophos.com promptly and in any event by no later than 12 noon on 11 November 2019. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

No profit forecasts, estimates or quantified financial benefits statements

 

No statement in this announcement is intended as a profit forecast, profit estimate or quantified benefits statement for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Sophos for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Sophos.

 

Requesting hard copy documents

 

In accordance with Rule 30.3 of the Code, Sophos Shareholders, persons with information rights and participants in Sophos Share Plans may request a hard copy of this announcement by contacting Sophos' registrars, Link Asset Services, during business hours on +44 (0)371 664 0321 or at Link Asset Services 34 Beckenham Road Beckenham Kent BR3 4TU. For persons who receive a copy of this announcement in electronic form or via a website notification, a hard copy of this announcement will not be sent unless so requested. Such persons may also request that all future documents, announcements and information to be sent to you in relation to the Acquisition should be in hard copy form.

 

Electronic Communications

 

Please be aware that addresses, electronic addresses and certain other information provided by Sophos Shareholders, persons with information rights and other relevant persons for the receipt of communications from Sophos may be provided to Bidco during the offer period as required under Section 4 of Appendix 4 of the Code to comply with Rule 2.11(c).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SOAMMMGMZRLGLZM
Date   Source Headline
2nd Mar 20203:20 pmRNSForm 8.3 - Sophos Group PLC
2nd Mar 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:52 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:50 pmRNSForm 8.3 - Sophos Group plc
2nd Mar 202011:07 amRNSForm 8.5 (EPT/RI)
2nd Mar 202010:52 amRNSForm 8.5 (EPT/RI)Sophos Group plc
2nd Mar 202010:38 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
2nd Mar 20209:10 amRNSScheme of arrangement
2nd Mar 20207:30 amRNSSuspension-Sophos Group PLC
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group PLC
28th Feb 20203:03 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20202:44 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 20201:53 pmRNSHolding(s) in Company
28th Feb 20201:28 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 202011:37 amRNSForm 8.5 (EPT/RI)
28th Feb 202011:06 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
28th Feb 202010:27 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
27th Feb 20202:38 pmBUSFORM 8.3 - SOPHOS GROUP PLC
27th Feb 20202:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
27th Feb 20202:22 pmBUSForm 8.3 - Sophos Group PLC
27th Feb 20202:04 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20201:07 pmRNSScheme Timetable Update
27th Feb 202011:55 amRNSForm 8.3 - Sophos Group Plc
27th Feb 202011:28 amRNSForm 8.5 (EPT/RI)
27th Feb 202011:23 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
27th Feb 202010:43 amRNSForm 8.5 (EPT/NON-RI)- Sophos Group plc
27th Feb 202010:40 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20208:23 amRNSRule 2.9 Announcement
26th Feb 20206:15 pmRNSSophos Group
26th Feb 20204:41 pmRNSScheme Timetable Update
26th Feb 20204:29 pmRNSForm 8.3 - Sophos Group Plc
26th Feb 20203:30 pmRNSForm 8.3 - SOPH LN
26th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:19 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
26th Feb 20202:57 pmRNSForm 8 (DD) - Sophos Group Plc
26th Feb 20202:51 pmRNSDirector/PDMR Shareholding
26th Feb 20201:31 pmBUSFORM 8.3 - SOPHOS GROUP PLC
26th Feb 202011:26 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
26th Feb 202010:56 amRNSForm 8.5 (EPT/RI)
26th Feb 202010:34 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
25th Feb 20204:39 pmRNSForm 8.3 - Sophos Group plc
25th Feb 20203:43 pmRNSForm 8.5 (EPT/RI) - Amendment
25th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
25th Feb 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
25th Feb 20203:00 pmBUSForm 8.3 - SOPHOS GROUP PLC
25th Feb 20202:29 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.